A13_ CO Signed SSJ_redacted.pdf

PDF 465 KB Posted

Attached to
Notice of Intent to Sole Source - CBTRUS - Malignant and Non-Malignant Tumors
Solicitation number
2023-78280
Issued by

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

JUSTIFICATION FOR SOLE SOURCE PROCUREMENT (OPEN MARKET OR GSA)

UNDER $250,000

Sole source acquisitions may be used on a limited basis and only when the Contracting Officer’s Representative (COR)/Program Official has provided sufficient justification and the Contracting Officer has determined that the circumstances warrant such action. The content for a justification must contain detailed facts and rationale to justify the sole source acquisition. Soliciting from a single source must be done in accordance with FAR 13.106-1(b) or 8.405-6. At a minimum, the following information must be included:

Identification of Program Office, Contracting Activity, and Proposed Requirement, Justification and Program Office Certification:

A. Program Office:

National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, Cancer Surveillance Branch 1440 Buford Highway, Chamblee Campus Building 107, Mail Stop S107-4 Centers for Disease Control and Prevention Atlanta, GA 30341

B. Contracting Activity:

Centers for Disease Control and Prevention Office of Financial Resources Acquisition Branch PGO

C. Identification of Requirement:

1. Nature of Action to be Approved by Contracting Officer:

a. Sole source acquisition of: Evaluation and Analysis of Brain and Central Nervous System Malignant and non-Malignant Tumors

b. Procurement Request (PR) Number (if available): Click here to enter text.

2. Proposed Vendor and Estimated Procurement Amount (if available):

a. Proposed Vendor: Central Brain Tumor Registry of the United States

b. Estimated Procurement Amount: $240,000

3. Is the requirement on GSA Schedule? ☐ Yes ☒ No

If yes, provide schedule number: Click here to enter text.

qna4 Highlight

Rev. 5/14/19

D. Justification:

1. The justification for this non-competitive action is:

☐ In accordance with FAR 13.106-1(b)(1), “only one source [is] reasonably available” which states that, “For purchases not exceeding the simplified acquisition threshold. (i) Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name or industrial mobilization). (ii) Where a single source is identified to provide a portion of a purchase because that portion of the purchase specifies a particular brand-name item, the documentation in paragraph (b)(1)(i) of this section only applies to the portion of the purchase requiring brand-name item. The documentation should state it is covering only the portion of the acquisition which is brand- name.”

☐ Urgency ☐ Exclusive licensing agreements/Proprietary data ☐ Brand name required ☐ Industrial mobilization ☐ Other (e.g., compatibility, space issues, continuity, compatibility, etc.)

☒ In accordance with FAR 8.405-6 “Limiting Sources” which states that, “the only circumstances that may justify the action are – (A) An urgent and compelling need exists, and following the procedures would result in unacceptable delays; (B) Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized; or (C) In the interest of economy and efficiency, the new work is a logical follow-up to an original Federal Supply Schedule order provided that the original order was placed in accordance with the applicable Federal Supply Schedule ordering procedures. The original BPA must not have been previously issued under sole-source or limited-sources procedures.”

☐ Urgency ☒ Only One Source ☐ Logical Follow Up ☐ Brand name required

2. Other facts supporting sole source procurement:

a. What can this product/service do that other products/services cannot do?

The Central Brain Tumor Registry of the United States (CBTRUS) is the only population-based brain and CNS-specific cancer registry in the United States. Its database is comprised of the largest histology-specific aggregation of population-based data limited to the incidence of primary brain and CNS tumors in the United States, enabling evaluation and analysis of population-based incidence rates for all primary brain and CNS tumors by histopathology, behavior, site, age, sex, race, ethnicity, and geography. CBTRUS serves as the subject matter experts to the US cancer surveillance community on brain and CNS tumors. Their expertise is recognized as they are a sustaining member of the North American Association of Central Cancer Registries (a collaborative umbrella organization for cancer registries, governmental agencies, and other partners in North America that work to enhancing the quality and use of cancer registry data), a member of the Society for Neuro-Oncology, the National Cancer Registrars Association, the International Association of Cancer Registries, and a founding partner of the Brain Tumor

Rev. 5/14/19

Epidemiology Consortium. CBTRUS contributes its subject matter expertise on brain tumor classification, coding, and collection to national and international organizations including the International Agency for Research on Cancer of the World Health Organization.

b. What other products/services were considered and why did they not meet the need?

No other site-specific population-based primary brain and central nervous system tumor registry exists in the United States; and no other organization represents the level of brain and CNS tumor subject matter experts available through the CBTRUS.

Therefore, no other organizations were considered.

3. Program Office efforts to seek potential offerors:

Since no other site-specific population-based primary brain and central nervous system tumor registry exists in the United States and no other organization represents the level of brain and CNS tumor subject matter experts available through the CBTRUS, no other offerors were sought.

E. Program Office Certification:

I have reviewed this sole source justification and certify the justification is true and accurate to the best of my knowledge and adequate to support other than full and open competition.

Center/Institute/Office COR/Program Official Name/Title: Mary Elizabeth O’Neil, Epidemiologist

Center/Institute/Office: NCCDPHP/DCPC/CSB

COR/Program Official Signature: ________________________________________________

Certification Date: May 11, 2023

F. Contracting Office Certification:

I have fully relied on the information provided herein and hereby certify that this justification is accurate and complete to the best of my knowledge and belief:

Contracting Officer Name: ______________________________________________________

Contracting Officer Signature: ___________________________________________________

Certification Date: ____________________

Yes: Off
In accordance with FAR 131061b1 only one source is reasonably available which: Off
Urgency: Off
Exclusive licensing agreementsProprietary data: Off
Brand name required: Off
Industrial mobilization: Off
Other eg compatibility space issues continuity compatibility etc: Off
Urgency_2: Off
Logical Follow Up: Off
Brand name required_2: Off
2023-05-11T12:42:08-0400
Mary E. O'neil -S
Contracting Officer Name: Jerry Outley
2023-06-14T06:59:37-0400
Jerry Outley -S

Certification Date: 6-14-2023

File details come from the government source that posted it. Updated .